Abbott Diagnostics Quality System Violations Require Outside Audit By August

Abbott's pending sale of its diagnostics business to GE will not be affected by an FDA warning letter citing quality control problems at its Irving, Texas, plant, the company claims

More from Archive

More from Medtech Insight